CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 276 filers reported holding CUBIST PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,413,000 | -42.9% | 21,300 | -13.4% | 0.05% | -68.0% |
| Q4 2014 | $2,475,000 | +75.2% | 24,590 | +15.4% | 0.17% | +57.9% |
| Q3 2014 | $1,413,000 | -1.3% | 21,300 | +3.9% | 0.11% | 0.0% |
| Q2 2014 | $1,431,000 | -4.6% | 20,500 | 0.0% | 0.11% | -8.5% |
| Q1 2014 | $1,500,000 | +7.3% | 20,500 | +1.0% | 0.12% | -17.6% |
| Q4 2013 | $1,398,000 | – | 20,300 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AKANTHOS CAPITAL MANAGEMENT LLC | 50,500 | $3,526,000 | 10.49% |
| Palo Alto Investors LP | 1,526,916 | $106,609,000 | 7.94% |
| HealthCor Management, L.P. | 1,225,000 | $85,530,000 | 4.29% |
| SECTOR GAMMA AS | 192,490 | $13,440,000 | 3.18% |
| AMI ASSET MANAGEMENT CORP | 363,698 | $25,393,000 | 2.52% |
| EAGLE BOSTON INVESTMENT MANAGEMENT INC | 578,207 | $40,370,000 | 2.01% |
| TURNER INVESTMENTS LLC | 559,239 | $39,046,000 | 1.73% |
| Tekla Capital Management LLC | 263,772 | $18,417,000 | 1.69% |
| MAZAMA CAPITAL MANAGEMENT INC | 80,221 | $5,601,000 | 1.50% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,234,570 | $225,838,000 | 1.34% |